ATHA
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Jun 25 closing price
Capitalization
12.18M
53 days until earnings call
AWKNF
Price
$0.07
Change
-$0.02 (-25.00%)
Updated
Dec 13 closing price
Capitalization
2.76M
Interact to see
Advertisement

ATHA vs AWKNF

Header iconATHA vs AWKNF Comparison
Open Charts ATHA vs AWKNFBanner chart's image
Athira Pharma
Price$0.31
Change+$0.01 (+3.33%)
Volume$196.04K
Capitalization12.18M
Awakn Life Sciences
Price$0.07
Change-$0.02 (-25.00%)
Volume$45.4K
Capitalization2.76M
ATHA vs AWKNF Comparison Chart in %
Loading...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHA vs. AWKNF commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Buy and AWKNF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ATHA: $0.31 vs. AWKNF: $0.06)
Brand notoriety: ATHA and AWKNF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 28% vs. AWKNF: 100%
Market capitalization -- ATHA: $12.18M vs. AWKNF: $2.76M
ATHA [@Biotechnology] is valued at $12.18M. AWKNF’s [@Biotechnology] market capitalization is $2.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileAWKNF’s FA Score has 0 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • AWKNF’s FA Score: 0 green, 5 red.
According to our system of comparison, ATHA is a better buy in the long-term than AWKNF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish.

  • ATHA’s TA Score: 5 bullish, 5 bearish.

Price Growth

ATHA (@Biotechnology) experienced а +0.65% price change this week, while AWKNF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

ATHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHA($12.2M) has a higher market cap than AWKNF($2.76M). AWKNF YTD gains are higher at: 0.000 vs. ATHA (-46.821). AWKNF has higher annual earnings (EBITDA): -2.4M vs. ATHA (-77.65M). ATHA has more cash in the bank: 36.7M vs. AWKNF (506K). AWKNF has higher revenues than ATHA: AWKNF (57.2K) vs ATHA (0).
ATHAAWKNFATHA / AWKNF
Capitalization12.2M2.76M443%
EBITDA-77.65M-2.4M3,233%
Gain YTD-46.8210.000-
P/E RatioN/AN/A-
Revenue057.2K-
Total Cash36.7M506K7,253%
Total Debt1.12MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ATHA
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NLSP2.370.10
+4.41%
Nls Pharmaceutics Ltd
SYF64.930.19
+0.29%
Synchrony Financial
FHI43.49-0.12
-0.28%
Federated Hermes
PTLO11.40-0.09
-0.78%
Portillo's
GLDG0.73-0.01
-0.80%
GoldMining

AWKNF and

Correlation & Price change

A.I.dvisor tells us that AWKNF and IVEVF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AWKNF and IVEVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AWKNF
1D Price
Change %
AWKNF100%
N/A
IVEVF - AWKNF
25%
Poorly correlated
N/A
ATHA - AWKNF
21%
Poorly correlated
+4.70%
MBCOF - AWKNF
20%
Poorly correlated
N/A
ASPHF - AWKNF
10%
Poorly correlated
N/A
AKESF - AWKNF
7%
Poorly correlated
N/A
More